Your browser doesn't support javascript.
loading
Next Directions in the Neuroscience of Cancers Arising outside the CNS.
Amit, Moran; Anastasaki, Corina; Dantzer, Robert; Demir, Ihsan Ekin; Deneen, Benjamin; Dixon, Karen O; Egeblad, Mikala; Gibson, Erin M; Hervey-Jumper, Shawn L; Hondermarck, Hubert; Magnon, Claire; Monje, Michelle; Na'ara, Shorook; Pan, Yuan; Repasky, Elizabeth A; Scheff, Nicole N; Sloan, Erica K; Talbot, Sebastien; Tracey, Kevin J; Trotman, Lloyd C; Valiente, Manuel; Van Aelst, Linda; Venkataramani, Varun; Venkatesh, Humsa S; Vermeer, Paola D; Winkler, Frank; Wong, Richard J; Gutmann, David H; Borniger, Jeremy C.
Affiliation
  • Amit M; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Anastasaki C; Department of Neurology, Washington University, St. Louis, Missouri.
  • Dantzer R; Department of Symptom Research, The University of Texas MD Anderson Cancer Center Houston, Texas.
  • Demir IE; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, Germany; Neural Influences in Cancer (NIC) International Research Consortium, Munich, Germany.
  • Deneen B; Center for Cancer Neuroscience and Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
  • Dixon KO; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Egeblad M; Departments of Cell Biology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Gibson EM; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California.
  • Hervey-Jumper SL; Department of Neurological Surgery and Weill Neuroscience Institute, University of California, San Francisco, San Francisco, California.
  • Hondermarck H; Cancer Neuroscience Laboratory, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan NSW 2308, Australia.
  • Magnon C; Laboratory of Cancer and Microenvironment-National Institute of Health and Medical Research (INSERM), Institute of Biology François Jacob-Atomic Energy Commission (CEA), University of Paris Cité, University of Paris-Saclay, Paris, France.
  • Monje M; Department of Neurology and Neurological Sciences, Stanford University, Stanford, California.
  • Na'ara S; Howard Hughes Medical Institute, Stanford, California.
  • Pan Y; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Repasky EA; Department of Symptom Research, The University of Texas MD Anderson Cancer Center Houston, Texas.
  • Scheff NN; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sloan EK; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Talbot S; Hillman Cancer Center, Department of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Tracey KJ; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Victoria, Australia.
  • Trotman LC; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
  • Valiente M; The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.
  • Van Aelst L; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
  • Venkataramani V; Brain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Venkatesh HS; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
  • Vermeer PD; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
  • Winkler F; Department of Functional Neuroanatomy, Institute for Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany.
  • Wong RJ; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Gutmann DH; Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota.
  • Borniger JC; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
Cancer Discov ; 14(4): 669-673, 2024 Apr 04.
Article in En | MEDLINE | ID: mdl-38571430
ABSTRACT

SUMMARY:

The field of cancer neuroscience has begun to define the contributions of nerves to cancer initiation and progression; here, we highlight the future directions of basic and translational cancer neuroscience for malignancies arising outside of the central nervous system.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurosciences / Neoplasms Limits: Humans Language: En Journal: Cancer Discov Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurosciences / Neoplasms Limits: Humans Language: En Journal: Cancer Discov Year: 2024 Document type: Article